Launching Spring 2027

The retinal literature, distilled

Four times a year, our editorial board picks the papers that matter in retina and practising experts explain why. A few minutes’ reading, with a link to the full article whenever you want to go deeper.

An open-access quarterly from Kugler Publications. Issue 1 appears in Spring 2027.

Sign up for Issue 1

What is Retina Review

What was published, what matters, and why

Every quarter, more than a thousand papers on the retina are published: clinical trials, imaging studies, surgical technique, genetics, pharmacotherapy. Nobody can read them all.

Retina Review reads the literature for you. Our editorial board selects the papers of real clinical or scientific importance, and a specialist in the field writes a short commentary on each: what the study found, how strong the evidence is, and what it means for your patients.

Each issue is published as a PDF. Every commentary and abstract is also online, searchable and linked to the original article. Retina Review is open access, made possible by our sponsors.

For readers

Read at the depth you have time for

Each paper is presented in layers. Scan the highlights in minutes, or follow a paper all the way to the full article.

Highlights

The key point of each commentary in a sentence or two.

Expert commentary

What the paper found, how strong the evidence is, and what it means in the clinic.

Abstract

The original abstract with authors, journal, keywords and full citation.

Full article

A direct link to the paper on the publisher’s website. Access terms may apply.

Four issues a year
Every issue as a PDF
Search by topic, journal or commentator
Open access

Stay up to date

Get each new issue by email

Sign up and we will send you Issue 1 in Spring 2027, and every issue after that. We only email you when there is something worth reading, and you can unsubscribe at any time.

How it works

AI assists. Experts decide.

Software can summarise a paper in seconds. It has never examined a patient or performed a vitrectomy. So we use AI where it saves time, and people where judgement counts.

AI does the legwork

AI screens every newly published abstract, flags likely candidates and suggests a topic, so nothing important slips through.

Editors decide

Every paper in Retina Review is selected by our editorial board. The algorithm proposes; people choose.

Experts explain

Our commentators see patients and operate. They read a paper with the clinic and the operating theatre in mind, and they read between the lines.

  1. Literature sweep

    Each quarter, the newly published retinal literature is retrieved from PubMed.

  2. AI-assisted screening

    Every abstract is screened and likely candidates are flagged for the editorial board.

  3. Editorial selection

    The editorial board selects the papers of real clinical or scientific importance.

  4. Expert commentary

    A specialist in the field writes a short commentary on each paper.

  5. Publication

    The Kugler team edits and typesets the issue, online and as a PDF.

For contributors

Become one of our founding commentators

We are building an international pool of commentators: retinal specialists, surgeons, imaging experts and scientists with the knowledge and the ambition to take part.

  • A focused format: one paper, one short commentary, with clear guidelines.
  • Our editorial team takes care of language editing, layout and publication.
  • Invitations match your expertise, and you decide how often you contribute.
  • Co-authored commentaries are welcome.
  • Your commentaries are published under your name and collected on your contributor profile.

Register your interest

For sponsors

Reach the retina community

Retina Review is open access for ophthalmologists and retinal specialists worldwide, from residents to senior consultants. Our sponsors make that possible, and their brand appears alongside the research these clinicians rely on.

Discuss sponsorship

  • Full-page advertisements

    In every quarterly PDF issue.

  • Banner positions

    On retina-review.com, alongside the commentaries and abstracts.

About

Published by Kugler Publications

Retina Review is published by Kugler Publications, the Amsterdam-based specialist publisher in ophthalmology. Kugler also produces International Glaucoma Review, the journal of the World Glaucoma Association, on which the Retina Review format builds.

Retina Review is run by an editorial board led by Managing Editor George Lambrou MD, whose career in ophthalmology spans glaucoma and retina, including roles at Bayer and Novartis. The members of the editorial board will be announced ahead of the first issue.

Managing Editor

George Lambrou MD

Athens, Greece

Editorial board to be announced